Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
limited-time offer
Enjoy this offer
* See conditions on site
Capitalization 14.6B 16.23B P/E ratio 2024 *
105x
P/E ratio 2025 * 65.2x
Enterprise value 18.5B 20.58B EV / Sales 2024 *
5.44x
EV / Sales 2025 * 4.94x
Free-Float
35.03%
Yield 2024 *
0.29%
Yield 2025 * 0.38%
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.59%
1 week-5.31%
Current month-5.57%
1 month-2.97%
3 months-4.38%
6 months-32.39%
Current year-29.32%
More quotes
1 week
225.80
Extreme 225.8
249.50
1 month
225.80
Extreme 225.8
252.00
Current year
199.50
Extreme 199.5
383.70
1 year
199.50
Extreme 199.5
383.70
3 years
199.50
Extreme 199.5
631.60
5 years
157.30
Extreme 157.3
631.60
10 years
19.00
Extreme 18.9975
631.60
More quotes
Director TitleAgeSince
Chief Executive Officer 59 99-04-30
Director of Finance/CFO 53 Mar. 31
Chief Operating Officer 68 00-12-31
Manager TitleAgeSince
Director/Board Member 60 02-08-31
Chairman 67 07-03-31
Director/Board Member 55 00-12-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+1.59%-5.31%-35.36%-59.28%16.18B
+10.26%+2.11%-44.54%-68.64%2.99B
-0.38%-4.21%+59.81%-22.87%1.45B
+1.39%-8.03%+48.67%+209.25%1.5B
+0.10%-5.04%+5.27% - 1.33B
-0.68%+0.54%+47.02%-48.02%990M
+1.74%+6.13%-23.79% - 788M
+1.71%+1.23%-38.86%-65.56%743M
-0.37%+3.45%+41.25%-41.94%626M
+2.31%-2.52%-37.82%-59.16%489M
Average +1.77%-1.40%+2.16%-19.53% 2.71B
Weighted average by Cap. +2.25%-3.63%-19.64%-41.42%
See all sector performances
2024 *2025 *
Net sales 3.4B 3.78B 3.7B 4.12B
Net income 159M 177M 251M 280M
Net Debt 3.91B 4.34B 3.68B 4.1B
More financial data * Estimated data
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
14,143
Calendar
More about the company
Date Price Change Volume
24-09-06 237.30 +0.76% 1,057
24-09-05 235.50 +1.99% 76,524
24-09-04 230.90 -2.16% 83,135
24-09-03 236.00 -0.67% 62,195
24-09-02 237.60 -4.73% 81,167

Delayed Quote Xetra, September 05, 2024 at 11:35 am EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
235.50EUR
Average target price
267.50EUR
Spread / Average Target
+13.59%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW